A Safety and Tolerability Study of GSK2982772, in Single (in Both Fed and Fasted States) and Repeat Oral Doses in Healthy Male Subjects

Clinical trial NCT02302404 · COMPLETED

Trial details

NCT number: NCT02302404
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Inflammatory Bowel Diseases

Start date: 2015-01-06
Primary completion: 2016-03-05
Enrollment: 79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.